Non-inferior self-cut mesh for pelvic organ prolapse procedure

Non-inferior self-cut mesh for pelvic organ prolapse procedure

Physician Information Staff

WEDNESDAY, Sept., Feb. 21, 2022 (HealthDay News) — Using the same titanium-coated polypropylene mesh, the surgical success rate with self-cut mesh is no less than that of a commercial mesh kit for the transvaginal treatment of severe pelvic organ prolapse (POP), according to a study published online in September. 16″ Open JAMA Network.

Juan Chen, MD, Ph.D., of the Chinese Academy of Medical Sciences and the Union Medical College of Beijing in Beijing, and colleagues conducted a randomized clinical trial to assess the efficacy and safety of titanium-coated self-cut polypropylene mesh (169 patients) versus pre-cut commercial mesh kit (167 patients) for transvaginal surgical treatment of women with severe symptomatic POP.

The researchers found that 95.9% of the self-cut mesh group met the definition of surgical success, which was not lower than the surgical success rate achieved in the mesh group (87.4%). There was no significant difference in the frequency of Clavien-Dindo grade 1 to 3 perioperative complications (7.2% in the self-cut mesh group versus 12.4% in the mesh group). At one year, the rates of vaginal mesh exposure were similar (2.4% in the self-cut mesh group versus 4.8% in the mesh group). Finally, there was a savings of $2,481.00 (40.4%) with the use of self-cut mesh when comparing median total hospitalization costs.

People also read…

“Self-cut mesh procedures may be beneficial for some patients in low- and middle-income countries,” the authors write.

#Noninferior #selfcut #mesh #pelvic #organ #prolapse #procedure

Leave a Comment

Your email address will not be published.